Lijun Wu

1.2k citations
39 papers · 961 indexed · h-index 15
Topics
Natural product bioactivities and synthesis (6 papers)Phytochemistry and Biological Activities (5 papers)Plant-based Medicinal Research (4 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Lijun Wu

38 papers receiving 935 citations

Peers

Lijun Wu
Comparison fields: 5 of 98
  • Molecular Biology 367
  • Pharmacology 344
  • Genetics 253
  • Oncology 174
  • Pharmacology 160
Replace Jouko Uusitalo with:
Jouko Uusitalo Finland
Mi‐Sook Dong South Korea
Craig B. Marcus United States
Qingyu Zhang United States
Morag McFadyen United Kingdom
R Lubet United States
Atsushi Kawase Japan
Yoko Otake United States
Wilart Pompimon Thailand
Naomi Mizuno Japan
Lijun Wu relative to Jouko Uusitalo Finland Jouko Uusitalo's profile →
Citations per field
00.5×3.6×
Jouko Uusitalo · 1×
Citations per year

Countries citing papers authored by Lijun Wu

Since Specialization
Citations

This map shows the geographic impact of Lijun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Wu more than expected).

Fields of papers citing papers by Lijun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Wu. The network helps show where Lijun Wu may publish in the future.

Co-authorship network of co-authors of Lijun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Wu. A scholar is included among the top collaborators of Lijun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Wu. Lijun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 35
2 13
3 63
4 22
5 27
6 41
7 72
8 12
9 11
10
Chemical constituents from the stem bark of Melia azedarach L.
1
11
A novel natural dammarane-type triterpene saponin from the leaves of Panax ginseng
1
12
A Novel Sesquiterpene from Curcuma longa
5
13 371
14
A new isocoumarin from Isatis indigotica Fort.
1
15 27
16
[Verification of a new processing technology for pilot production of Aconitum coreanum (Lévl.) Raipaics].
1
17
Studies on the chemical constituents of the rhizomes of Imperata cylindrica
1
18 1
19 21
20
STUDIES ON ANTIBACTERIAL CONSTITUENTS OF SYRINGA OBLATA LINDL
1

About Lijun Wu

Lijun Wu is a scholar working on Pharmacology, Pharmaceutical Science and Pharmacology, having authored 39 papers that have together received 961 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (6 papers), Phytochemistry and Biological Activities (5 papers) and Plant-based Medicinal Research (4 papers). The work is most often cited by research in Pharmacology (344 citations), Pharmacology (160 citations) and Genetics (253 citations). Lijun Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Brant R. Ward, Yan Jin, A. M. Storniolo, Zereunesay Desta, L LI, D M Nikoloff, Anne Nguyen, Todd C. Skaar, Xue‐Long Sun and Ying Liu. Their work appears in journals such as Blood, Cancer Research and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026